How Ozempic Could Save America’s Health System

“Rich people get Ozempic. Poor people get body positivity.” That was one of the iconic lines from a “South Park” special in May dubbed “The End of Obesity.” The show focused its trademark satire on semaglutide, a class of type-2 diabetes drugs that have become popular in the last few years, particularly among wealthier Americans, […]